Related Experiment Videos

The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket characteristics

F H Seeger¹, D Arnold, T Dumrese

¹Institute of Cell Biology, Department of Immunology, Auf der Morgenstelle 15 (Verfügungsgebäude), D-72076 Tübingen, Germany.

|June 20, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases-the IKF-080/AIO-QUINTIS trial.

ESMO gastrointestinal oncology·2026

Second-line FOLFOX chemotherapy for patients with advanced biliary tract cancers pretreated with cisplatin/gemcitabine: a systematic review and meta-analysis.

ESMO gastrointestinal oncology·2026

European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'.

ESMO gastrointestinal oncology·2026

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study.

Transfusion·2026

Production of radioactive traceable reference materials for measuring radioactive pollutants in the environment.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025

Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC).

ESMO open·2025

See all related articles